510(k) K050206
K050206 is an FDA 510(k) premarket notification submitted by Microgenics Corp. for the device "CEDIA TACROLIMUS ASSAY". The FDA issued a decision of Substantially Equivalent on March 15, 2005. The device falls under product code MLM (Enzyme Immunoassay, Tracrolimus), a Class II device regulated under 21 CFR 862.1678. Microgenics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 15, 2005
- Date Received
- January 28, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Tracrolimus
- Device Class
- Class II
- Regulation Number
- 862.1678
- Review Panel
- TX
- Submission Type